Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBR
5026
Sabine Royalty Trust
SBR
$1.06B
| $2.48M | ﹤0.01% |
40,743
+22,977
| +129% | +$1.55M |
|
|
GTY
5027
Getty Realty Corp
GTY
$2.05B
| $2.48M | ﹤0.01% |
93,559
-4,933
| -5% | -$134K |
|
5028
CALL
Takeda Pharmaceutical
TAK
$56.3B
| $2.48M | ﹤0.01% |
176,300
-1,100
| -0.6% | -$15.7K |
|
|
AUY
5029
CALL
DELISTED
Yamana Gold, Inc.
AUY
| $2.48M | ﹤0.01% |
532,200
-65,100
| -11% | -$353K |
|
5030
CALL
ProShares UltraShort Yen
YCS
$30M
| $2.47M | ﹤0.01% |
86,600
+3,000
| +4% | +$78.8K |
|
|
EVBG
5031
PUT
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.47M | ﹤0.01% |
88,700
-74,200
| -46% | -$3.01M |
|
|
MODN
5032
DELISTED
MODEL N, INC.
MODN
| $2.47M | ﹤0.01% |
96,728
-27,337
| -22% | -$681K |
|
|
JBTM
5033
JBT Marel
JBTM
$6.23B
| $2.47M | ﹤0.01% |
22,396
+16,098
| +256% | +$1.85M |
|
5034
PUT
Amphenol
APH
$206B
| $2.47M | ﹤0.01% |
76,800
+14,800
| +24% | +$515K |
|
5035
PUT
Lantheus
LNTH
$6.59B
| $2.47M | ﹤0.01% |
37,400
+12,900
| +53% | +$813K |
|
5036
iShares MSCI France ETF
EWQ
$332M
| $2.47M | ﹤0.01% |
82,172
+2,037
| +3% | +$66.9K |
|
5037
State Street SPDR Global Dow ETF
DGT
$630M
| $2.46M | ﹤0.01% |
+25,637
| New | +$2.69M |
|
5038
Goldman Sachs Hedge Industry VIP ETF
GVIP
$587M
| $2.46M | ﹤0.01% |
35,152
+19,067
| +119% | +$1.51M |
|
5039
CALL
Iridium Communications
IRDM
$5.32B
| $2.46M | ﹤0.01% |
65,600
-30,700
| -32% | -$1.15M |
|
|
IMPX
5040
DELISTED
AEA-Bridges Impact Corp
IMPX
| $2.46M | ﹤0.01% |
248,447
-2,283,041
| -90% | -$22.6M |
|
5041
CALL
ProShares UltraShort Euro
EUO
$33.1M
| $2.46M | ﹤0.01% |
81,000
+68,900
| +569% | +$2.03M |
|
5042
PUT
Methanex
MEOH
$4.34B
| $2.46M | ﹤0.01% |
64,400
+35,300
| +121% | +$1.74M |
|
5043
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.48B
| $2.46M | ﹤0.01% |
23,340
+6,626
| +40% | +$751K |
|
5044
SunPower Inc
SPWR
$44.3M
| $2.46M | ﹤0.01% |
250,000
-40
| -0% | -$392 |
|
5045
Amkor Technology
AMKR
$14.7B
| $2.45M | ﹤0.01% |
144,698
+66,655
| +85% | +$1.27M |
|
5046
Traeger
COOK
$164M
| $2.45M | ﹤0.01% |
11,542
+4,453
| +63% | +$1.24M |
|
5047
iShares MSCI Netherlands ETF
EWN
$738M
| $2.45M | ﹤0.01% |
69,961
-69,736
| -50% | -$2.66M |
|
5048
McCormick & Company Non-Voting
MKC
$14.7B
| $2.45M | ﹤0.01% |
29,459
-13,333
| -31% | -$1.26M |
|
5049
CALL
Bread Financial
BFH
$4.58B
| $2.45M | ﹤0.01% |
66,100
-76,300
| -54% | -$3.89M |
|
5050
3D Systems Corp
DDD
$616M
| $2.45M | ﹤0.01% |
252,375
+54,211
| +27% | +$633K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.